Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$353M |
| 2 |
Televisa
TV
|
+$92.4M |
| 3 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$38.2M |
| 4 |
DST
DST Systems Inc.
DST
|
+$36.8M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$315M |
| 2 |
CAB
Cabela's Inc
CAB
|
+$56.7M |
| 3 |
NXP Semiconductors
NXPI
|
+$48.7M |
| 4 |
TSMC
TSM
|
+$24.7M |
| 5 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.9% |
| 2 | Technology | 14.05% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Eastman Chemical
EMN
$8B
| $268K | ﹤0.01% |
3,565
+1
| +0% | +$72 |
|
552
Regeneron Pharmaceuticals
REGN
$78.5B
| $262K | ﹤0.01% |
715
+95
| +15% | +$36.1K |
|
553
Allstate
ALL
$68B
| $260K | ﹤0.01% |
+3,504
| New | +$247K |
|
|
RTN
554
DELISTED
Raytheon Company
RTN
| $260K | ﹤0.01% |
+1,834
| New | +$261K |
|
|
AGEN
555
Agenus
AGEN
$312M
| $258K | ﹤0.01% |
3,187
| – | – |
|
556
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
| $256K | ﹤0.01% |
+5,168
| New | +$243K |
|
557
Vanguard Information Technology ETF
VGT
$139B
| $256K | ﹤0.01% |
+16,888
| New | +$254K |
|
558
Kraft Heinz
KHC
$30.7B
| $252K | ﹤0.01% |
2,881
-77
| -3% | -$6.59K |
|
559
DuPont de Nemours
DD
$18.5B
| $250K | ﹤0.01% |
+1,728
| New | +$241K |
|
560
Thermo Fisher Scientific
TMO
$213B
| $241K | ﹤0.01% |
1,707
+225
| +15% | +$33.2K |
|
561
Vanguard Consumer Staples ETF
VDC
$7.97B
| $241K | ﹤0.01% |
+1,798
| New | +$240K |
|
562
NVIDIA
NVDA
$4.86T
| $240K | ﹤0.01% |
+89,960
| New | +$188K |
|
563
Emerson Electric
EMR
$83.9B
| $238K | ﹤0.01% |
+4,278
| New | +$230K |
|
564
SPDR Gold Trust
GLD
$131B
| $237K | ﹤0.01% |
2,164
+281
| +15% | +$32.6K |
|
565
Enterprise Products Partners
EPD
$82.3B
| $236K | ﹤0.01% |
+8,727
| New | +$227K |
|
|
STI
566
DELISTED
SunTrust Banks, Inc.
STI
| $235K | ﹤0.01% |
+4,277
| New | +$214K |
|
|
IPG
567
DELISTED
Interpublic Group of Companies
IPG
| $234K | ﹤0.01% |
10,005
-299
| -3% | -$6.91K |
|
568
Hewlett Packard
HPE
$63.4B
| $231K | ﹤0.01% |
17,194
+272
| +2% | +$3.63K |
|
569
NextEra Energy
NEE
$181B
| $230K | ﹤0.01% |
7,700
+1,104
| +17% | +$33K |
|
|
ADPT
570
DELISTED
Adeptus Health Inc
ADPT
| $229K | ﹤0.01% |
29,951
-6
| -0% | -$110 |
|
571
Prudential Financial
PRU
$42.4B
| $228K | ﹤0.01% |
+2,187
| New | +$207K |
|
|
ATVI
572
DELISTED
Activision Blizzard
ATVI
| $227K | ﹤0.01% |
6,287
| – | – |
|
573
Galicia Financial Group
GGAL
$7.99B
| $221K | ﹤0.01% |
8,200
+800
| +11% | +$23K |
|
574
Cummins
CMI
$87.5B
| $217K | ﹤0.01% |
1,591
+1
| +0.1% | +$134 |
|
575
Trane Technologies
TT
$101B
| $217K | ﹤0.01% |
+2,898
| New | +$209K |
|
Similar funds
Ken Fisher's Q4 2016 Portfolio in Review
As of Q4 2016, Ken Fisher held 837 positions worth $57.4B, up 2% from $56.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q4 2016 filing shows 61 new, 208 increased, 401 reduced and 54 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Europe 50 ETN Series B: 174,286 shares worth $18.7M. The largest sale was FI Enhanced Global High Yield Exchange Traded Notes, an estimated $315M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q4 2016 buy was Barclays ETN+ FI Enhanced Europe 50 ETN Series B: 174,286 shares worth $18.7M.
- Ken Fisher added most to UBS AG FI Enhanced Global High Yield ETN in Q4 2016, an estimated $353M increase.
- Ken Fisher's biggest Q4 2016 reduction was FI Enhanced Global High Yield Exchange Traded Notes, cutting an estimated $315M.
- Ken Fisher fully exited Cabela's Inc in Q4 2016, selling an estimated $56.7M.
- Ken Fisher's ten largest holdings make up 22% of its $57.4B portfolio in Q4 2016.
- Ken Fisher opened 61 new positions and closed 54 in Q4 2016.
- Ken Fisher's portfolio value rose 2% quarter-over-quarter to $57.4B.
Based on Fisher Asset Management's 13F filing for Q4 2016, filed 10 Jan 2017.